Agios Pharmaceuticals, Inc. (0HB0.L)
USD 41.74
(-0.05%)
USD 41.74
(-0.05%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 26.82 Million | 14.24 Million | - | - | 117.91 Million | 94.38 Million |
| Cost of Revenue | 9.5 Million | 20.26 Million | 18.77 Million | 18.77 Million | 17.93 Million | 8.56 Million |
| Gross Profit | 17.31 Million | -6.02 Million | -18.77 Million | -18.77 Million | 99.97 Million | 85.81 Million |
| Operating Expenses | 408.8 Million | 383.02 Million | 359.64 Million | 317.14 Million | 526.3 Million | 448.29 Million |
| Selling, General and Administrative Expenses | 119.9 Million | 111.67 Million | 111.9 Million | 106.12 Million | 123.5 Million | 106.97 Million |
| Research and Development Expenses | 288.9 Million | 271.34 Million | 247.73 Million | 211.02 Million | 402.8 Million | 341.32 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 418.31 Million | 403.28 Million | 378.41 Million | 335.91 Million | 544.24 Million | 456.86 Million |
| Operating Income | -391.48 Million | -389.04 Million | -378.41 Million | -335.91 Million | -426.33 Million | -362.47 Million |
| Interest Expense | - | - | - | 17.83 Million | - | - |
| Income Tax Expense | - | - | 27.9 Million | -1.93 Million | - | 7.01 Million |
| Earnings before Tax | -352.08 Million | -231.8 Million | -356.51 Million | -329.3 Million | -411.47 Million | -346.02 Million |
| Net Income | -352.08 Million | -231.8 Million | -384.41 Million | -327.37 Million | -411.47 Million | -346.02 Million |
| Earnings Per Share Basic | -6.33 | -4.23 | -6.36 | -4.74 | -6.86 | -6.03 |
| Earnings Per Share Diluted | -6.33 | -4.23 | -6.36 | -4.74 | -6.86 | -6.03 |
| Weighted Average Shares Outstanding | 55.65 Million | 54.78 Million | 60.44 Million | 68.99 Million | 59.99 Million | 57.41 Million |
| Weighted Average Shares Outstanding (Diluted) | 55.65 Million | 54.78 Million | 60.44 Million | 68.99 Million | 59.99 Million | 57.41 Million |
| Gross Margin | 0.65 | -0.42 | - | - | 0.85 | 0.91 |
| EBIT Margin | -12.88 | -26.02 | - | - | -3.47 | -3.76 |
| Profit Margin | -13.13 | -16.28 | - | - | -3.49 | -3.67 |
| EBITDA | -345.46 Million | -213.24 Million | -337.73 Million | -310.53 Million | -394.85 Million | -355.3 Million |
| Earnings Before Tax Margin | -14.60 | -27.32 | - | - | -3.62 | -3.84 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 8.96 Million | 8.61 Million | 8.18 Million | 7.1 Million | 26.82 Million | 7.39 Million |
| Cost of Revenue | 783 Thousand | 78.89 Million | 1.97 Million | 1.98 Million | 9.5 Million | 2.25 Million |
| Gross Profit | 8.18 Million | -70.28 Million | 6.21 Million | 5.11 Million | 17.31 Million | 5.14 Million |
| Operating Expenses | 110.99 Million | 33.95 Million | 98.28 Million | 111.39 Million | 408.8 Million | 106.04 Million |
| Selling, General and Administrative Expenses | 38.53 Million | 35.53 Million | 31.01 Million | 35.3 Million | - | 25.82 Million |
| Research and Development Expenses | 72.45 Million | 77.4 Million | 67.27 Million | 76.08 Million | - | 80.21 Million |
| Other Expenses | 1.34 Million | - | - | - | - | - |
| Cost and Expenses | 111.77 Million | 112.85 Million | 100.26 Million | 113.38 Million | 418.31 Million | 108.29 Million |
| Operating Income | -102.81 Million | -105.81 Million | -92.07 Million | -106.27 Million | -391.48 Million | -100.89 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 53.12 Million | - | - | - | - | - |
| Earnings before Tax | 1 Billion | -96.11 Million | -81.54 Million | -95.94 Million | -352.08 Million | -91.32 Million |
| Net Income | 947.91 Million | -96.11 Million | -81.54 Million | -95.94 Million | -352.08 Million | -91.32 Million |
| Earnings Per Share Basic | 16.65 | -1.69 | -1.45 | -1.72 | - | -1.64 |
| Earnings Per Share Diluted | 16.22 | -1.69 | -1.45 | -1.72 | - | -1.64 |
| Weighted Average Shares Outstanding | 56.93 Million | 56.8 Million | 56.38 Million | 55.89 Million | 55.65 Million | 55.8 Million |
| Weighted Average Shares Outstanding (Diluted) | 58.43 Million | 56.8 Million | 56.38 Million | 55.89 Million | 55.65 Million | 55.8 Million |
| Gross Margin | 0.91 | -8.16 | 0.76 | 0.72 | 0.65 | 0.70 |
| EBIT Margin | 111.67 | -12.10 | -11.08 | -14.76 | - | -13.42 |
| Profit Margin | 105.75 | -11.16 | -9.96 | -13.51 | -13.13 | -12.34 |
| EBITDA | 1 Billion | -104.22 Million | -90.72 Million | -104.87 Million | - | -99.27 Million |
| Earnings Before Tax Margin | -11.47 | -12.28 | -11.24 | -14.96 | -14.60 | -13.64 |
HDF
3OY1
BLK
FYNBK
CLF
SUI